Philips Respironics CoughAssist T70 airway clearance technology -- an effective alternative to traditional suctioning methods

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130108:nPnMM36853

MURRYSVILLE, Pa., Jan. 8, 2013 /PRNewswire/ -- Philips Respironics, a unit of
Royal Philips Electronics (NYSE: PHG, AEX: PHIA), today announced that it has
received 510(k) clearance to market its latest advancement in airway clearance
technology for enhanced patient care in the hospital or in the home. The new
CoughAssist T70 provides an effective, comfortable alternative to traditional
suctioning methods and may minimize the risk of pneumonia and infections that
can lead to hospital readmissions.

To view the multimedia assets associated with this release, please click:
http://www.multivu.com/mnr/59828-philips-respironics-coughassist-t70-airway-clearance-technology

(Photo: http://photos.prnewswire.com/prnh/20130108/MM36853 )

"Philips Respironics is dedicated to providing patients, their caregivers and
clinical teams with innovative solutions that improve patient care," said Jay
Vreeland, director, North American marketing, home respiratory, Philips Home
Healthcare Solutions. "The CoughAssist T70 couples clinically-proven technology
with evolutionary enhancements that make it simpler to operate, conveniently
flexible and more sensitive to the user's breathing pattern for a more natural
treatment."

The CoughAssist T70 next generation device incorporates proven technology that's
effective, and easy to use. It clears secretions from the lungs by gradually
applying positive air pressure to the airway and then rapidly shifting to
negative air pressure. The shift in pressure creates a high expiratory flow that
simulates a deep, natural cough. Instead of introducing a suction catheter into
the airway, air is delivered through a facemask, a mouthpiece or through a
simple adapter that allows the device to function with an endotracheal or
tracheostomy tube, reducing discomfort and risk of infection. In addition, new
design and technology updates have been developed to enhance patient and
clinician use.

* Cough-Trak - A unique triggering feature with automatic sensitivity allows
patients to initiate therapy and synchronize treatment with their own breathing
pattern;
* Portability - Weighing less than 9 lbs., it is compact, lightweight and easy
to transport;
* Flexibility - In addition to AC and DC power options, a detachable lithium ion
battery allows up to four treatments on a single charge;
* Ease of use - A user-friendly digital interface and preset prescriptions
simplify setup and initiating therapy;
* Results - New data management software allows patients and caregivers to
monitor tidal volume, peak cough flow and oxygen saturation levels to enhance
therapy effectiveness.

The CoughAssist T70 comes with an SD card, hose clip, air filter, patient
circuit, adult mask, carrying case, and AC power cord.

Information is available online at www.philips.us/coughassistT70.

About Royal Philips Electronics

Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6
billion and employs approximately 121,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, home and portable
entertainment and oral healthcare. News from Philips is located at
www.philips.com/newscenter.

SOURCE Philips Respironics

Maryellen Bizzack, Philips Home Healthcare Solutions, +1-724-387-5006,
Maryellen.bizzack@philips.com